Clinical Trial Detail

NCT ID NCT02815059
Title Study of Pts With Philadelphia Chromosome-Pos ALL With Comb of Ibrutinib, Dasatinib, and Prednisone
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Utah
Indications

acute lymphoblastic leukemia

Therapies

Dasatinib + Ibrutinib + Prednisone

Age Groups: senior adult

No variant requirements are available.